Diabetes Projects

---

Warwick Evidence are developing an expertise in Diabetes-related projects. We have undertaken the following projects:

Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)

Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy Review of TA301 (ID1421)

Dapagliflozin and empagliflozin, in combination with insulin, for treating type 1 diabetes (ID1217)

Ertugliflozin in monotherapy and dual therapy for treating type 2 diabetes (ID1158) (TA572)

Ertugliflozin triple therapy for treating type 2 diabetes (ID1160)

Dapagliflozin for type 1 diabetes (ID1478)

 

Other diabetic works include:

Non-pharmacological interventions for Diabetes (HTA 16330)

Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy (HTA 19510)

Empagliflozin for type 2 diabetes (ID641)

Dapagliflozin in combination therapie for treating type 2 Diabetes (TA288)

Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes (HTA1317701)